SWAN Impact Network is pleased to announce a follow-on investment in Eisana.
Eisana is an oncology solution company providing a platform for multiple products to address cancer treatment issues, including a patent-pending, cryo-compression device for hands and feet to wear before, during, and after infusion to prevent chemotherapy-induced peripheral neuropathy.
They are also developing a patent pending, state-of-the-art scalp cooling device to wear before, during, and after infusion to prevent chemotherapy-induced hair loss. The device is portable and can cool for long periods of time, necessary to have success even for drugs that take longer to leave the body.
SWAN previously invested in the company earlier in 2023.